I, G., VE, C. R., J, M., S, E. F., K, M., M, M., . . . A, G. (2025). Relation between dabrafenib plus trametinib-induced pyrexia and age in BRAF V600-mutated metastatic melanoma patients: A post hoc analysis of the real-world ELDERLYMEL study.
Chicago Style CitationI, González-Barrallo, et al. Relation between Dabrafenib Plus Trametinib-induced Pyrexia and Age in BRAF V600-mutated Metastatic Melanoma Patients: A Post Hoc Analysis of the Real-world ELDERLYMEL Study. 2025.
MLA CitationI, González-Barrallo, et al. Relation between Dabrafenib Plus Trametinib-induced Pyrexia and Age in BRAF V600-mutated Metastatic Melanoma Patients: A Post Hoc Analysis of the Real-world ELDERLYMEL Study. 2025.
Warning: These citations may not always be 100% accurate.